Just Released: "United Arab Emirates Pharmaceuticals & Healthcare Report Q4 2013"
A regional leader in terms of healthcare provision, there are changes ahead in the UAE as the Gulf Cooperation Council introduces a unified pricing system. This is likely to generate a reduction in drug prices to bring the cost of pharmaceuticals in line with larger market, such as Saudi Arabia, and this may change the dynamics of the market - changing the role that more expensive, branded and patented drugs play. Price cuts are already affecting the market, with multinationals...
View full press release